PNC-27 FAQ: Sourcing, Purity, Storage & Shipping

This technical FAQ provides laboratory researchers with explicit analytical guidance regarding PNC-27 sourcing, purity standards, molecular mechanisms, storage parameters, and reconstitution protocols. Discover how PX1 Research maintains lot-to-lot consistency and rigorous ISO 17025 analytical standards for in vitro experimental applications.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

This technical FAQ provides laboratory researchers with explicit analytical guidance regarding PNC-27 sourcing, purity standards, molecular mechanisms, storage parameters, and reconstitution protocols. Discover how PX1 Research maintains lot-to-lot consistency and rigorous ISO 17025 analytical standards for in vitro experimental applications.

Reviewed by PX1 Research scientific team

Key takeaways

  • **What is PNC-27?** PNC-27 is a synthetic membrane-active research peptide engineered by attaching a p53-derived HDM-2 binding domain (residues 12–26) to a transmembrane-penetrating leader sequence (MRP or penetratin derivative).
  • **How does PNC-27 interact with target cell membranes?** In vitro assays demonstrate that PNC-27 selectively targets cancer cells exhibiting membrane-bound HDM-2 protein.
  • **What purity level is guaranteed for PX1 Research PNC-27?** Every batch of [PNC-27 peptide](/product/pnc-27) supplied by PX1 Research meets or exceeds a baseline purity threshold of ≥98.0% as determined by High-Performance Liquid Chromatography (HPLC) analytical testing.
  • **Where are PX1 Research peptides synthesized?** All PX1 Research peptides are manufactured within USA-based, state-of-the-art facilities operating under strict Good Manufacturing Practice (GMP) compliance and ISO 17025 laboratory accreditations.

1. PNC-27 Identification & Basic Overview

**What is PNC-27?** PNC-27 is a synthetic membrane-active research peptide engineered by attaching a p53-derived HDM-2 binding domain (residues 12–26) to a transmembrane-penetrating leader sequence (MRP or penetratin derivative). In preclinical models, it is evaluated primarily for its ability to target tumor cell membranes expressing surface HDM-2.

**What is the designated research role of PNC-27?** As a membrane-active anticancer peptide, PNC-27 is investigated in preclinical research for selectively binding membrane-bound HDM-2 on cancer cells and inducing rapid cell lysis via transmembrane pore formation, operating entirely independent of the intracellular p53 signaling pathway.

**Is PNC-27 approved for human or clinical use?** No. PNC-27 is manufactured exclusively as a research compound for laboratory research use only. It is not intended for human consumption, clinical treatment, veterinary administration, or diagnostic procedures under any circumstances.

2. Molecular Mechanism of Action & Receptor Targets

**How does PNC-27 interact with target cell membranes?** In vitro assays demonstrate that PNC-27 selectively targets cancer cells exhibiting membrane-bound HDM-2 protein. Upon binding the HDM-2 target on transformed cell surfaces, the peptide inserts into the lipid bilayer, initiating localized membrane disruption.

**What structural mechanism causes cellular lysis in preclinical models?** Preclinical studies suggest that upon membrane insertion, PNC-27 oligomerizes to form transmembrane pores. This leads to rapid loss of membrane integrity, extracellular ion influx, and subsequent cell necrosis within minutes of contact in culture media.

**Does PNC-27 require intracellular p53 pathways to function?** No. In vitro data indicate that PNC-27 activity does not depend on intracellular p53 activation, nuclear translocation, or apoptosis cascades. The pore-forming mechanism acts via direct physical alteration of the plasma membrane on cells expressing surface HDM-2. Researchers interested in broader peptide libraries can explore our all peptides catalog for related membrane-active and target-specific compounds.

3. Purity Specifications & Quality Assurance

**What purity level is guaranteed for PX1 Research PNC-27?** Every batch of PNC-27 peptide supplied by PX1 Research meets or exceeds a baseline purity threshold of ≥98.0% as determined by High-Performance Liquid Chromatography (HPLC) analytical testing.

**How is batch identity and structural integrity verified?** Batch identity is confirmed using Mass Spectrometry (MS) to verify the exact molecular weight and amino acid Sequence integrity, ensuring absolute freedom from truncated fragments or synthesis side-products.

**Are PX1 Research compounds tested for bacterial endotoxins?** Yes. All batches undergo quantitative chromogenic LAL testing to verify endotoxin levels remain below strictly defined laboratory limits (<0.01 EU/μg), protecting sensitive cell lines from non-specific inflammatory signaling during in vitro assays.

4. Sourcing & Analytical Documentation (COA)

**Where are PX1 Research peptides synthesized?** All PX1 Research peptides are manufactured within USA-based, state-of-the-art facilities operating under strict Good Manufacturing Practice (GMP) compliance and ISO 17025 laboratory accreditations.

**How can researchers verify the Certificate of Analysis (COA)?** Every lot is shipped with a lot-specific Certificate of Analysis. Investigators can also verify analytical spectra, HPLC chromatograms, and MS data directly via our dedicated online COA verification hub.

**Why is independent third-party testing essential for research peptides?** Third-party testing by accredited ISO 17025 laboratories eliminates supplier bias, confirming that mass spectrometry peaks and purity values accurately reflect the physical contents of the vial before experimental deployment.

5. Packaging Specifications & Vial Configurations

**What physical state is PNC-27 supplied in?** PNC-27 is supplied as a lyophilized (freeze-dried) sterile powder sealed in glass vials under an inert nitrogen atmosphere to prevent oxidation and moisture degradation during transport.

**What vial sizes are standard for PNC-27 research?** PX1 Research offers standardized vial masses (such as 5 mg or 10 mg lyophilized cake) tailored for standard laboratory assay preparation and serial dilution protocols.

**Can institutional laboratories arrange custom bulk orders?** Yes. Institutional buyers, academic departments, and high-throughput research facilities can request bulk quantities, specialized vial sizing, or custom packaging through our wholesale lab portal.

6. Reconstitution & Laboratory Handling Protocols

**What diluents are recommended for PNC-27 reconstitution?** PNC-27 should be reconstituted using sterile Bacteriostatic Water or Sterile Water for Injection, depending on the specific sensitivity of the downstream cell culture assay.

**How should reconstitutions be calculated for precise concentrations?** Researchers should utilize the interactive PX1 Reconstitution Calculator to determine precise solvent volumes required to reach targeted working concentrations (e.g., mM or μM stock solutions).

**What physical techniques prevent peptide shear during reconstitution?** Allow the vial to equalize to room temperature prior to solvent addition. Inject the diluent slowly along the glass wall and gently swirl the vial. Never shake vigorously, as mechanical agitation can disrupt secondary protein structures or cause foaming.

7. Storage Conditions & Long-Term Stability

**How should lyophilized PNC-27 be stored upon receipt?** Lyophilized PNC-27 standard vials should be stored desiccated at -20°C for short-to-medium term storage, or at -80°C for long-term preservation exceeding six months.

**What is the stability profile of reconstituted PNC-27 solution?** Once reconstituted, liquid stock solutions should be aliquoted into single-use polypropylene tubes and stored at -20°C or -80°C. Avoid repeated freeze-thaw cycles, which degrade peptide integrity over time.

**How long does reconstituted PNC-27 maintain stability at 4°C?** Stock solutions kept at 2–8°C should generally be utilized within 3 to 7 days to maintain optimal assay activity and prevent hydrolytic degradation.

8. Shipping & Logistics Specs

**Where do PX1 Research shipments originate?** All orders are dispatched directly from centralized, climate-controlled distribution centers located in California and Arizona to ensure fast transit nationwide.

**What is the standard order fulfillment timeline?** Orders placed before cut-off times Monday through Friday are processed with same-day shipping, minimizing travel duration and sample thermal exposure.

**Does lyophilized PNC-27 require cold-chain shipping?** Lyophilized peptides exhibit high thermal stability during short transit windows at ambient temperatures. However, protective temperature-controlled packaging is utilized when environmental conditions warrant.

9. Comparative Analysis: PNC-27 and Related Compounds

**How does PNC-27 compare to other cytotoxic and targeted research compounds?** When evaluating membrane-active oncology tools, researchers often compare PNC-27 against related lead structures such as PNC-28, which contains a modified p53 domain sequence targeting membrane HDM-2, or broader p53-pathway Modulators like Nutlin-3a and selective apoptosis-inducing agents such as FOXO4-DRI.

**What distinguishes PNC-27 from intracellular MDM2/p53 inhibitors?** Small-molecule MDM2 inhibitors act intracellularly to release p53 from MDM2 repression, requiring functional p53 to trigger apoptosis. In contrast, in vitro assays confirm that PNC-27 acts extracellularly on surface-expressed HDM-2, destroying cell membrane permeability independent of p53 mutation status.

10. Regulatory Status & Institutional Compliance

**What regulatory restrictions govern the purchase of PNC-27?** PNC-27 is restricted strictly to qualified research laboratories, university faculties, and industrial R&D entities. It is strictly sold as a chemical reagent for laboratory research use only.

**How should unused PNC-27 solutions be disposed of in the lab?** Disposal must comply with local biological and chemical hazard guidelines. Residual peptide solution should be processed according to standard hazardous chemical waste handling procedures at your institution. Learn more about structural research protocols on our peptides research portal.

Frequently Asked Questions

What is the primary mechanism of PNC-27 in cancer research?

Preclinical studies suggest PNC-27 selectively binds membrane-bound HDM-2 on cancer cells, inducing transmembrane pore formation and rapid necrotic cell lysis independent of p53 pathway status.

What purity level does PX1 Research guarantee for PNC-27?

PX1 Research guarantees a purity of ≥98.0% verified via HPLC and Mass Spectrometry, accompanied by lot-specific Certificates of Analysis from ISO 17025 accredited testing facilities.

How should lyophilized PNC-27 be stored?

Lyophilized PNC-27 should be stored at -20°C for short-term preservation or at -80°C for extended long-term storage, protected from light and moisture.

What is the recommended diluent for reconstituting PNC-27?

Sterile Bacteriostatic Water or Sterile Water for Injection is recommended for reconstituting PNC-27, depending on specific cell culture sensitivity and experimental design.

Can reconstituted PNC-27 undergo multiple freeze-thaw cycles?

No. Reconstituted stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent protein degradation associated with repeated freeze-thaw cycles.

Does PNC-27 require intact p53 to induce cell lysis?

In vitro data indicate that PNC-27 acts directly via membrane disruption on HDM-2 expressing cells, maintaining efficacy regardless of whether the cell's internal p53 gene is mutated or wild-type.

Where does PX1 Research ship PNC-27 from?

All orders ship directly from centralized fulfillment facilities in California and Arizona, featuring same-day shipping on orders placed Monday through Friday.

Is PNC-27 suitable for clinical administration?

No. PNC-27 is manufactured exclusively for in vitro laboratory research and preclinical testing. It is strictly not for human or veterinary administration.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.